Insiders Supernus Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-09-20 EDT			5-day change	1st Jan Change
31.82 ^USD	-0.96%		+2.98%	+9.95%

09-04	Supernus Pharmaceuticals, Inc. Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 04:30 PM
08-19	Sector Update: Health Care Stocks Edge Higher Premarket Monday	MT

Supernus Pharmaceuticals, Inc. Announces Retirement of John M. Siebert from the Board of Directors	04-24	CI
Supernus Pharmaceuticals Insider Sold Shares Worth $511,677, According to a Recent SEC Filing	03-25	MT
Supernus Pharmaceuticals Insider Sold Shares Worth $436,573, According to a Recent SEC Filing	03-21	MT
Supernus Pharmaceuticals, Inc. Announces Executive Changes	02-21	CI
Supernus Pharmaceuticals Insider Sold Shares Worth $259,151, According to a Recent SEC Filing	11-17	MT
Insider Sell: Supernus Pharmaceuticals	23-09-01	MT
Insider Sell: Supernus Pharmaceuticals	23-08-29	MT
Supernus Pharmaceuticals, Inc. Appoints Bethany L. Sensenig to Board of Directors	23-08-21	CI
Insider Sell: Supernus Pharmaceuticals	23-03-16	MT
Insider Sell: Supernus Pharmaceuticals	23-02-06	MT
Insider Sell: Supernus Pharmaceuticals	23-01-20	MT
Insider Sell: Supernus Pharmaceuticals	23-01-19	MT
Insider Sell: Supernus Pharmaceuticals	23-01-19	MT
Insider Sell: Supernus Pharmaceuticals	22-12-22	MT
Insider Sell: Supernus Pharmaceuticals	22-12-02	MT
Insider Sell: Supernus Pharmaceuticals	22-11-15	MT
Insider Sell: Supernus Pharmaceuticals	22-08-23	MT
Insider Sell: Supernus Pharmaceuticals	22-08-18	MT
Insider Sell: Supernus Pharmaceuticals	22-08-17	MT
Insider Sell: Supernus Pharmaceuticals	22-08-11	MT

No results for this search